Literature DB >> 10457224

Calcium-independent haemolysis via the lectin pathway of complement activation in the guinea-pig and other species*.

Y Zhang1, C Suankratay, X Zhang, D R Jones, T F Lint, H Gewurz.   

Abstract

We previously reported that complement-dependent haemolysis of sheep erythrocytes (E) coated with mannan (M) and sensitized with human mannan-binding lectin (MBL) via the lectin pathway in man occurs in Mg-EGTA and requires alternative pathway amplification. Calcium was required for MBL binding to E-M, but once the E-M-MBL intermediate was formed, MBL was retained and haemolysis occurred in the absence of calcium. Comparable or greater lectin pathway haemolysis in the absence of calcium was observed upon incubation of E-M-MBL in guinea-pig, rat, dog and pig sera, and was further investigated in the guinea-pig, in which titres were much higher ( approximately 14-fold) than in man, and in contrast to humans, greater than classical pathway haemolytic activity. As in human serum, no lysis was observed in C4- or C2-deficient guinea-pig serum until purified C4 or C2, respectively, were restored. However, lectin pathway haemolytic activity in the guinea-pig did not require the alternative pathway. Removal (>98%) of factor D activity by three sequential passages through Sephadex G-75, resulting in serum which retained a normal classical pathway but no alternative pathway haemolytic activity, did not reduce the ability of guinea-pig serum to mediate haemolysis via the lectin pathway. Further, the C3-convertase formed via the lectin pathway (E-M-MBL-C4,2) lysed in C2-deficient guinea-pig but not human serum chelated with EDTA, a condition which precludes alternative pathway amplification. Thus, lectin pathway haemolysis occurs efficiently in guinea-pig serum, in the absence of calcium and without requirement for alternative pathway amplification. The guinea-pig provides a model for studying the assembly and haemolytic function of a lectin pathway which contrasts with the lectin pathway of man, and allows for comparisons that may help clarify the role of this pathway in complement biology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457224      PMCID: PMC2326880          DOI: 10.1046/j.1365-2567.1999.00810.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.

Authors:  R J Pickering; M R Wolfson; R A Good; H Gewurz
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

2.  Isolation and characterization of a mannan-binding protein from rabbit serum.

Authors:  Y Kozutsumi; T Kawasaki; I Yamashina
Journal:  Biochem Biophys Res Commun       Date:  1980-07-31       Impact factor: 3.575

3.  Isolation and characterization of mannan-binding proteins from chicken liver.

Authors:  S Oka; T Kawasaki; I Yamashina
Journal:  Arch Biochem Biophys       Date:  1985-08-15       Impact factor: 4.013

4.  A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum.

Authors:  F Praz; M C Roque Antunes Barreira; P Lesavre
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

5.  Isolation and characterization of a mannan-binding protein from rat liver.

Authors:  Y Mizuno; Y Kozutsumi; T Kawasaki; I Yamashina
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

6.  Isolation and characterization of a mannose/N-acetylglucosamine/fucose-binding protein from rat liver.

Authors:  R Townsend; P Stahl
Journal:  Biochem J       Date:  1981-01-15       Impact factor: 3.857

7.  Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.

Authors:  C Suankratay; C Mold; Y Zhang; T F Lint; H Gewurz
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

8.  Isolation and characterization of a mannan-binding protein from human serum.

Authors:  N Kawasaki; T Kawasaki; I Yamashina
Journal:  J Biochem       Date:  1983-09       Impact factor: 3.387

9.  A group of bactericidal factors conserved by vertebrates for more than 300 million years.

Authors:  M Kawakami; I Ihara; S Ihara; A Suzuki; K Fukui
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

10.  Mechanism of action of factor D of the alternative complement pathway.

Authors:  P H Lesavre; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  5 in total

1.  A missense mutation (c.1963A<G) of the complementary component 2 (C2) gene is associated with serum Ca⁺⁺ concentrations in pigs.

Authors:  Jae-Bong Lee; Chae-Kyoung Yoo; Eun-Ji Jung; Jung-Hye Hwang; Bo-Young Seo; Byeong-Woo Kim; Hyun-Tae Lim; Jung-Gyu Lee; In-Cheol Cho; Hee-Bok Park
Journal:  Mol Biol Rep       Date:  2012-07-05       Impact factor: 2.316

2.  Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.

Authors:  C Suankratay; C Mold; Y Zhang; T F Lint; H Gewurz
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

3.  Enhancement of lectin pathway haemolysis by immunoglobulins.

Authors:  C Suankratay; Y Zhang; D Jones; T F Lint; H Gewurz
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

4.  Complement opsonization of nanoparticles: Differences between humans and preclinical species.

Authors:  Yue Li; Guankui Wang; Lynn Griffin; Nirmal K Banda; Laura M Saba; Ernest V Groman; Robert Scheinman; S Moein Moghimi; Dmitri Simberg
Journal:  J Control Release       Date:  2021-09-02       Impact factor: 11.467

5.  Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent.

Authors:  Nandita Bose; Anissa S H Chan; Faimola Guerrero; Carolyn M Maristany; Xiaohong Qiu; Richard M Walsh; Kathleen E Ertelt; Adria Bykowski Jonas; Keith B Gorden; Christine M Dudney; Lindsay R Wurst; Michael E Danielson; Natalie Elmasry; Andrew S Magee; Myra L Patchen; John P Vasilakos
Journal:  Front Immunol       Date:  2013-08-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.